West Lafayette, IN, United States of America

David Thomas Jonaitis

This inventor holds 24 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Celgene Corporation, Canna Chemistries LLC, Astrazeneca Ab. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Thomas Jonaitis. Retrieved from https://idiyas.com/inventor/david-thomas-jonaitis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 9)

% Patents Active = 95.8

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

Brookstone, IN (US) (2011)
West Lafayette, IN (US) (2008 - 2015)
Waltham, MA (US) (2015)
Brookston, IN (US) (2013 - 2024)

Company Filing History:

Canna Chemistries LLC

Acadia Pharmaceuticals Inc.

patents

5. 2 out of 9

Astrocyte Pharmaceuticals, Inc.

Aurigene Oncology Limited

patents

9. 1 out of 100

Idenix Pharmaceuticals, Inc.

patents

10. 1 out of 1

Mutual Pharamaceutical Company, Inc.

Takeda Pharmaceuticals U.s.a., Inc.

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Crystalline Forms

Polymorphic Compounds

Solid Compositions

Trofinetide

Psilocin

Δ-THC

Sulfonamide

Naloxol-PEG Conjugate

Colchicine Complex

Beta-L-2'-Deoxythymidine

Ticagrelor Co-Crystal

Solid Forms

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492167 - Crystalline forms of trofinetide (2025-12-09),

2. 12358874 - Crystalline salts of psilocin (2025-07-15),

3. 12295962 - Polymorphic compounds and uses thereof (2025-05-13),

4. 12090137 - Solid Δ-tetrahydrocannabinol (Δ-THC) compositions (2024-09-17),

5. 11970447 - Crystalline salts of psilocin (2024-04-30),

6. 11866420 - Hydrochloride salt forms of a sulfonamide structured kinase inhibitor (2024-01-09),

7. 11827600 - Crystalline forms of trofinetide (2023-11-28),

8. 11478447 - Solid Δ-tetrahydrocannabinol (Δ-THC) compositions (2022-10-25),

9. 11406629 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2022-08-09),

10. 11324769 - Polymorphic compounds and uses thereof (2022-05-10),

11. 10835522 - Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2020-11-17),

12. 10765693 - Polymorphic compounds and uses thereof (2020-09-08),

13. 10376503 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2019-08-13),

14. 9974780 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2018-05-22),

15. 9968627 - Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof (2018-05-15),

Title: David Thomas Jonaitis - A Pioneer in Inventions

Introduction:

David Thomas Jonaitis is a distinguished inventor based in West Lafayette, IN (US). Known for his unwavering passion for innovation and problem-solving, he has made significant contributions to the industry with his inventive spirit.

Latest Patents:

- Solid Δ-tetrahydrocannabinol (Δ-THC) compositions: Jonaitis' invention focuses on a solid Δ-THC composition beneficial for pharmaceutical or nutraceutical purposes. The composition involves a molar ratio of Δ-THC to powder former to create a flowable Δ-THC powder, opening new avenues for medication administration and incorporation into food and beverage products.

- Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer: This patent reveals solid forms including 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, offering novel pharmaceutical compositions with diverse applications for treating various disorders.

Career Highlights:

With an impressive portfolio of 17 patents, David Thomas Jonaitis has showcased his innovative prowess in the realm of inventions. His dedication to creating groundbreaking solutions has led to patents that revolutionize the pharmaceutical and nutraceutical industries.

Collaborations:

Throughout his career, Jonaitis has collaborated with esteemed companies such as Celgene Corporation and AstraZeneca AB. His partnerships with professionals like G Patrick Stahly and Ho-Wah Hui have further enriched his inventive journey, fostering a culture of innovation and knowledge exchange.

Conclusion:

David Thomas Jonaitis stands as a true pioneer in the world of inventions, consistently pushing boundaries and reshaping industries with his innovative creations. His patents not only demonstrate his technical expertise but also underscore his commitment to advancing healthcare and pharmaceutical innovation. As a respected figure in the industry, Jonaitis continues to inspire future generations of inventors with his remarkable contributions.

Profile summary based on public USPTO records.